Please use this identifier to cite or link to this item:
Title: Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.
Austin Authors: Chua, Kyra Y L ;Laurent, Frederic;Coombs, Geoffrey W;Grayson, M Lindsay ;Howden, Benjamin P 
Affiliation: Infectious Diseases
Issue Date: 1-Jan-2011
Publication information: Clinical Infectious Diseases; 52(1): 99-114
Abstract: There is significant diversity in methicillin-resistant Staphylococcus aureus (MRSA) clones arising in the community worldwide, with considerable geographical differences in typical antimicrobial resistance profiles. Many community clones of MRSA have a non-multidrug resistant antimicrobial profile, providing increased options for empirical and directed therapy of infections caused by these strains. However, the recent description of increasing non-β lactam resistance in community clones of MRSA, especially USA300, provides a timely warning for clinicians making decisions about therapy for patients potentially infected with these strains. Continued monitoring of global epidemiology and emerging drug resistance data is critical for the effective management of these infections.
DOI: 10.1093/cid/ciq067
Journal: Clinical Infectious Diseases
Type: Journal Article
Subjects: Anti-Bacterial Agents.pharmacology
Community-Acquired Infections.epidemiology.microbiology
Drug Resistance, Bacterial
Methicillin-Resistant Staphylococcus aureus.drug effects.isolation & purification
Microbial Sensitivity Tests
Staphylococcal Infections.epidemiology.microbiology
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Dec 5, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.